chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient stated she developed hives 3-4 hours following Hepatitis B vaccination. She states no hives on face but had every where else. "Heart was racing" but patient denies any difficulty breathing or swallowing. Patient states she took dicyclomine morning of vaccination )1st and only dose).
Leaving pt after 20 min monitoring and felt dizziness as exiting site.  Client reports taking meds this morning + not eating.   O2 95%, BP 100/70, after eating a slice of pizza  + sniker bar she reports feeling better.  Hydrated with water.  Monitor additional 30 min and scorted to her car.  Recently hospitalized due to asthma 2 weeks ago.
like little temperature; achy joints; bad headache that usually she has, but it gets a little more achy; This is a spontaneous report received from Pfizer sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration on 13May2021 (lot number and expiry date: unknown) as 2nd dose, single, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 for COVID-19 immunisation. On 14May2021, the patient experienced a reaction like little temperature, achy joints, and bad headache that usually she has, but it gets a little more achy. She took Excedrin, a type of Aspirin as treatment for the events. She was asking if those reactions can spread to others. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Info has been received from a physician concerning a 39 year old female nurse with no verified history of varicella, who was in contact with an adult female healthcare worker who was vaccinated with a dose of varicella virus vaccine live. On 10/17/05, the healthcare worker experienced an adverse experience. The pt was exposed to the healthcare worker on 10/20/05. At the time of exposure, the pt was taking the following medications: hydrochlorothiazide (+)losartan potassium, sertraline hydrochloride (Zoloft), unspecified therapy and hormonal contraceptives (unspecified). The pt had never been vaccinated with a dose of varicella virus vaccine live but on 11/7/05 (previously reported an 11/10/05), the pt developed a generalized chickenpox rash characterized by 19-20 small vesicles on erythematous base. The lesions were distributed on the pt's head, face, chest and abdomen. It was noted that the pt also had an enlarged posterior cervical mass. A VZV culture was taken from a vesicle on 11/11/05 and determined to be BgL (+) wild type. It was reported that the pt recovered. Additional info is not expected.
patient reports a creepy crawly sensation that starts in right shoulder blade and wraps around to right breast. very bothersome. began about 1 week after vacccine
Upon wakening the next day he experienced muscle weakness in the lower extremities and overall tiredness "flu like fatigue".
pt recvd vax in lt arm @ clinic on 14JAN96;arm swollen, area 2 1/2 x 2 inch macular erythematous, warmth, tenderness @ inj site;w/sl raised linear area inferior to punctual site;rx compresses, APAP
I started itching within 30 minutes of receiving the vaccine. I had weird reaction that felt like burning through my veins in just my right arm. I had muscle aches, body aches, fatigue within my first day. I literally could not use my arm at all. The second dose I had soreness but I could still move it. I don't know if the nurse hit a pressure point or something but it felt like a 9-10 on the pain scale. It was horrible pain. There was 3-4 weeks that my shot was giving me a fever of 99.5. I could not move my arm for 7 days after the shot. I was progressively feeling a bit better. I had severe headaches for 3 whole days. I had to take my medication for migraine for days until June 13. I definitely spent most days sleeping if not taking my medications. I did experience some more mild headaches but nothing like the migraine of hell from days 7-10. It was mostly near the injection site that it hurt the most. I tried laying in bed for several days to rest.
Headache, Rash, Diarrhea, NauseaVomiting, Local Symptoms: Pain-discomfort, redness, swelling. General Symptoms: chills, headaches, joint pains, muscle pains, nausea, diarrhea, rash. Narrative:
breastfeed; has broken out in a rash all over his body; This spontaneous case was reported by a non-health professional and describes the occurrence of EXPOSURE VIA BREAST MILK (breastfeed) and RASH (has broken out in a rash all over his body) in a male patient of an unknown age exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) , while the mother received the product for COVID-19 vaccination.     No Medical History information was reported.    In August 2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. In August 2021, the patient was diagnosed with EXPOSURE VIA BREAST MILK (breastfeed) and RASH (has broken out in a rash all over his body). At the time of the report, EXPOSURE VIA BREAST MILK (breastfeed) and RASH (has broken out in a rash all over his body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Parent received the first dose of the Moderna vaccine two mornings ago and on yesterday morning child has rash to who m she breastfeed and also mentioned that Nothing else has changed in my diet to cause an allergy reaction. No concomitant medications were provided by reporter. No treatment medications were provided by reporter.
This spontaneous report as received from a registered nurse refers to a 6 month old patient of unknown gender. The patient's concurrent conditions, medical history and drug allergies were not reported. On 17-OCT-2016, the patient was vaccinated with improperly stored ROTATEQ, oral, (dose not reported) from lot # M019708 with expiry date: 25-OCT-2017 for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous temperature excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all the follow-up correspondence have been received. This is an amended report, as corrected. The reference type for the number US-009507513-1610USA014706 has been changed from Company Number to Linked Report. Sender's Comments: US-009507513-1610USA014706.
inadvertently given 0.3ml of 5-11 vaccine, so 50% extra vaccine.  never developed any sx
Pt got a rash on bottom of feet and stomach. No reaction around injection site. 6.25mg BENADRYL liquid given po.
A few days after getting my second dose, I was out playing sand volleyball. This is a normal thing for and do this frequently with ease. However that weekend after the second dose, I was playing and I suddenly was overcome and felt as if I was having a heat stroke. I ended up feeling this pain in my chest and a hard pounding and racing in my heart. It took about 45 minutes for this to stop. This continued to happen for about six months. Each time I had the pain and feeling in my chest and could have to bend over and apply pressure to the spot that was hurting to get it to stop. It felt as if I was having almost panic attacks that included this chest pain and elevated heart rate. I ended up going to the doctor after six months of experiencing this and they did an Echocardiogram and some blood work.
Received vaccine on 04/10/2006.  On 04/11/2006, woke up with temperature 103 degrees, eye and lip edema, body aches.
IMZ ADMINISTERED AUG 25TH - NO ISSUES. AUG 26TH-MILD SORENESS IN ARM. AUG 27TH- STOMACH ACHE BEGAN. AUG 28TH AND 29TH- SEVERE ABDOMINAL PAIN AND VOMITING. AUG 30TH AND 31ST- VERY WEAK.
severe diarrhea; sharp pain in lower back; tired more than usual; very little arm pain/soreness in her arm; sleepiness; exhausted; This is a spontaneous report received from a contactable consumer, the patient.   A 62-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number unknown), via an unspecified route of administration in Arm on an unspecified date in 2021 as DOSE 2, SINGLE for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number unknown), via an unspecified route of administration in Arm on an unspecified date in 2021 as DOSE 1, SINGLE for COVID-19 immunization and flipped out after her first. It was reported that some had the typical side effects, but the severe side effects the patient had, the patient had some kind of sharp pain in her lower back. The back pain was strange, it was not ongoing, but came on suddenly, acutely. The patient was at the hospital from 5:30 to 6pm on about, it would have been 27Mar2021, the patient got the vaccine later in the day, it was more than 24 hours, but less than 48 hours. The patient went in and was there for 12 hours at least, more than that. The patient got out about 7am the next morning. The lower back pain was sharper and painful, they said it was related to inflammation in lower intestine, which the patient thought was bizarre, as the patient left the ER, another guy was wheeled in with side effects. No further details provided. The patient experienced severe diarrhea on 28Mar2021, it was not ongoing, the patient got out of the ER on Sunday 28Mar2021. The patient had very little arm pain on an unspecified date in 2021, started within 24 hours of the injection, it was minimal for the patient, that lasted for maybe three days at most. The patient experienced sleepiness, no headache within 16 or 17 hours of injection, the patient got it at 11 or 12 in the morning. The next morning at 0400 or 0500, the patient woke up, could not go back to sleep, later that day, the patient wanted to go back, was exhausted, but the patient got up at 0400. The patient was unsure why she woke up and could not sleep, might be other reasons. The patient had concerns about the vaccine. The patient stated that the hope was the vaccine would prevent the patient from getting sick, in short term. The patient also experienced very tired, tired more than normal on an unspecified date in 2021. The patient stated that she was healthy. Patient underwent X-ray which showed inflammation in her lower intestine on an unspecified date in 2021. Outcome of the events tired more than usual, sleepiness and exhausted was unknown. Outcome of the events sharp pain in lower back, severe diarrhea and very little arm pain/soreness in her arm was reported as recovered on an unspecified date in 2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown demographics. No concurrent conditions or medical history were provided. On an unknown date, those patients were vaccinated with single doses of RECOMBIVAX HB injection (strength, dose, route of administration, lot# and expiry date unspecified), post both supported and not supported temperature excursions. No concomitant medications were reported. No patient had reported experiencing an adverse effect due to receipt of vaccination post temperature excursion. This is one of several reports from the same source. Additional information has been requested.
Fatigue; General Malaise; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 9-year-old male patient received BNT162b2 (BNT162B2), on 24May2022 at 19:00 as dose 3 (booster), single (Lot number: FL8094) at the age of 9 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Birth at 33.5 gestational weeks" (unspecified if ongoing); "Bilateral inguinal hernia" (unspecified if ongoing), notes: Bilateral inguinal hernia repair at 2 months and 4 years of age; "Left temporal lobe dermatoid cyst excision" (unspecified if ongoing), notes: Left temporal lobe dermatoid cyst excision at 1.5 years of age. The patient took concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: FK5127, Route of Administration: Intramuscular), administration date: 04Dec2021, when the patient was 8-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: FK5127, Route of Administration: Intramuscular), administration date: 07Nov2021, when the patient was 8-year-old, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 25May2022 at 15:00, outcome "not recovered"; MALAISE (non-serious) with onset 25May2022 at 15:00, outcome "not recovered", described as "General Malaise". Therapeutic measures were not taken as a result of fatigue, malaise.  Additional information: If covid prior vaccination: No. If covid tested post vaccination: No. Known allergies: No. Other medications in two weeks: daily vitamins  No follow-up attempts are possible. No further information is expected.
patient reported egg allergy and chicken allergy - monitored for 30 minutes with no reaction post administration
Feb 11, sore arm for one day; Feb 17 started with muscle and joint pain, especially tender right knee and overall not feeling well; Feb 18 felt lightheaded and weak with standing through out the day; Feb 19 weakness and lightheaded much worse, had several episodes of vomiting and become too weak to stand; went to ER
Adverse event: Vaccine was administered 16 days after beyond use date and is less effective. Treatment: Pt returning to our office for additional vaccine based on Pfizer and state recommendations.
Information has been received from a registered nurse referring to unspecified numbers of patients of unknown age and gender. There was no information about the patient's medical history and concurrent condition. On unknown dates between July 2015 and 11-SEP-2015, these patients were vaccinated with improperly stored oral, ROTATEQ (lot # K016314, expiration date: 05-JUN-2016 or lot # L004466, expiration date: 02-AUG-2016, strength, dose unknown) orally. There was no information about concomitant therapy. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient reports feeling hot and profuse sweating and immediately vomits. Refers that he has not eaten anything. Snack was offered and lower extremities got elevated. Medial emergency personnel evaluate patient. Doctor is notified. Patient is in observation for 30 minutes and reports feeling better.
Severe and debilitating pain at site of vaccination which is still present. Have limited use of arm.
Red, hard, and large swollen lump at injection site; Red, hard, and large swollen lump at injection site; Red, hard, and large swollen lump at injection site; Painful throbbing at injection site; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Red, hard, and large swollen lump at injection site), VACCINATION SITE ERYTHEMA (Red, hard, and large swollen lump at injection site), VACCINATION SITE SWELLING (Red, hard, and large swollen lump at injection site), VACCINATION SITE PAIN (Painful throbbing at injection site) and FATIGUE (Fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Family history included Penicillin allergy since an unknown date.    On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PAIN (Painful throbbing at injection site), FATIGUE (Fatigue) and NAUSEA (Nausea). On 01-Apr-2021, the patient experienced VACCINATION SITE INDURATION (Red, hard, and large swollen lump at injection site), VACCINATION SITE ERYTHEMA (Red, hard, and large swollen lump at injection site) and VACCINATION SITE SWELLING (Red, hard, and large swollen lump at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Mar-2021, NAUSEA (Nausea) had resolved. At the time of the report, VACCINATION SITE INDURATION (Red, hard, and large swollen lump at injection site), VACCINATION SITE ERYTHEMA (Red, hard, and large swollen lump at injection site), VACCINATION SITE SWELLING (Red, hard, and large swollen lump at injection site), VACCINATION SITE PAIN (Painful throbbing at injection site) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Received 2nd vaccine on 3/5/21 & developed symptoms on 3/6/21. Symptoms lasted 2 days. Symptoms included confusion, Fever > 100, Oxygen Saturation upper 80's, & body aches.
Extreme fatigue, muscle pain, headache starting on day one post injection. Appearance of red, hard rash around injection site and down left arm on day two.
Began feeling a little strange the following evening at about bed time. Woke up about 3:00 am with very, very bad headache. Next morning still had head ache, felt sick to the stomach. I was in bed all day somewhat dehydrated could not take even fruit juice which I threw up, had head ache all day and later in the day aches and pains in the body. All had lessened by that evening when I could take some food, felt more or less normal the next morning.
Patient stated that she felt hot and short of breath.  Patient was offered an ice pack and a pulse oximeter was placed on finger for obtaining O2 sat. Patient stated she felt flushed and that tongue and throat were tingling. EMS was called.  Attempted to transfer patient to a wheelchair to relocated patient to clinic emergency area. Patient passed out and onsite MD consulted. Epi pen administered at 1021 via R arm and vitals monitored until EMS arrived.  O2 sat 99%.  BP 180/86 and HR 126.  EMS arrived on site at 1040
Sign and sympton onset was 11/4/2022 Left eye vision blurred and dry, trouble smiling, trouble closing left eye.  Seen in the Emergency Department  - was given Over the counter eye drops, Anti Viral and Steroid (Prednisone and Valacyclovir)  Sign and symptoms are leveling off, not getting worse as of 14:45 11/7/22
Information has been received from a Licensed Practitioner Nurse concerning a 56 year old male patient with a history or "sinus issues" who on 07-DEC-2010 was vaccinated with a first dose of PNEUMOVAX 23 (lot#667914/1067Z). On 04-JAN-2011 a pneumococcal titer was done and was positive for only 4 pneumococcal types. It was unspecified if the patient sought medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
After 24 hrs:  severe burning throat all night, awoke with sore neck, sneezing. Arm felt like it was hit by a baseball bat.  The entire day, extreme exhaustion, heavy eyes, sore throat, mild runny nose.  That evening, sneezing, runny nose, coughing, scratchy, bright red throat.  Today, symptoms continue. Feel exhausted.  Prior to the vaccine, vibrantly healthy.
Flu shot given 12/10/2001. Several days later, complained of pruritis and rash over entire body that continues today 12/28/2001, despite treatment with corticosteroids (topical and IM).
pt recv vax 8AUG95 & 13FEB98 pt devel approx 15-20 lesions all over body w/o a fever;
pt devel a generalized papulovesicular rash (20 days from sibling's vax);pt completely covered w/more than 50 lesions described as a varicella like rash;systemic sx included nausea & sore throat;
43 year old female with a past medical history significant for asthma, anxiety, DM, migraines, thyroid papillary carcinoma who is presenting to the ED with an allergic reaction. She received her COVID vaccination at 1700. At approximately 1715 she felt a lump in her throat. Shortly after she felt as if her tongue/lips were tingling/becoming swollen and then she developed nausea. No rash or abdominal pain. No dyspnea or chest pain. All symptoms are consistent with prior episodes of anaphylaxis. She has had anaphylaxis to vaccinations in the past but was advised by her allergist to get the COVID vaccine today.  On arrival patient is quite anxious. Vital signs are stable. Her tongue is enlarged/mildly edematous, additionally appreciated mild lip/perioral swelling. There is no stridor or wheezing, no evidence of respiratory distress. Given examination findings, symptom description, findings concerning for anaphylaxis. As such, epinephrine promptly administered as well as solumedrol, famotidine, and benadryl. Shortly after the epinephrine she endorsed improvement in her swelling, though during benadryl administration she endorsed a sudden onset of subjective throat swelling/felt as if she could not breathe. Patient was reassessed, no change in initial examination findings, within a few minutes she felt her symptoms improve without intervention.A short while later she again felt as if her throat swelling was worsening, as such epinephrine dose re administered.  Following a 2.5 hour period of observation she endorsed continued improvement in her allergic symptoms, requested discharge home though continued observation offered. A course of prednisone prescribed, patient already with epi pen.  Patient discharged home.
pt recvd vax;rash w/ appearance of papules (like chicken pox) at time of vax;devel 15-20 papules on leg, head & scalp; also devel a low grade T & was fussy;
Rosacea; Postherpetic Neuralgia; Shingles; Information has been received from a lawyer regarding a case in litigation and referred to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 28-JAN-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, dose, route, lot# and expiration date were not reported). Shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered a rash in her face and redness and pain in her forehead area. The patient was diagnosed with shingles, rosacea and postherpetic neuralgia. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms had resulted in physical limitations not present prior to using the product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacturer, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events shingles, rosacea and postherpetic neuralgia was considered as not recovered. The events were considered related to zoster vaccine live (ZOSTAVAX).   The lawyer considered the events shingles, rosacea and postherpetic neuralgia to be disability.
Body/muscle aches, fever, headache, chills, sweating,  fatigue, abs excessive thirst.   Lasted about 18 hrs. Lingering headache, fatigue and thirst.